News summary

Cumulus Neuroscience Presents Data at the ISCTM 2026 Autumn Conference

Source: PR Newswire • Published: 16 Sept 2026, 22:00

Summarized by Masters of Longevity from PR Newswire.

Remote multimodal monitoring and brief digital cognitive screening: an approachable conference article previewing feasibility studies and trial-enrichment methods.

Cumulus Neuroscience Presents Data at the ISCTM 2026 Autumn Conference
Key Takeaways
  • A seven-week study in borderline personality disorder showed >85% adherence to cognitive and EEG sessions and ~90% median mood-assessment adherence.
  • In 15 complete participants with therapy-resistant depression, 98.7% of in-clinic and 90.5% of at-home behavioural sessions produced analysable data.
  • A two-minute symbol-coding digital task performed comparably to clinical benchmarks for Alzheimer’s trial pre-enrichment in prior AAIC data.
Read the full article at PR Newswire

Continue exploring

Recommended MoL Picks

MoL PickCreatine and Cancer: Why New Mouse Studies Point in Opposite DirectionsCreatine strengthened antitumour immune cells in one mouse study—and promoted metastasis through platelets in another. The apparent contradiction reveals why neither result is a supplement recommendation.MoL PickMelatonin and Heart Failure: What the Evidence Actually ShowsA 2025 study linked melatonin use with heart failure. A 2026 analysis found no significant association. Their different designs explain why the question remains open.MoL PickFrom Metrics to Better LivingEverstride’s May 2026 Consumer Health Market Briefing shows a wellness market moving from products to systems, from tracking to guidance, and from optimization to meaning. The next winners in longevity may not be the companies that measure the most. They may be the ones that help consumers translate health data into a life they actually want to live.